Cash & equivalents decreased 23.0%
Cash & equivalents changed -23.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -23.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Gross margin changed +2029 basis points from the comparable as-filed period.
Gross profit changed +183.7% from the comparable as-filed period.
Operating income changed -25.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed +26617 basis points from the comparable as-filed period.
Revenue changed +115.4% from the comparable as-filed period.
Selling, general & administrative changed +91.5% from the comparable as-filed period.
Stock-based compensation changed +65.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Research & development changed -15.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Net income changed -0.6% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.